Loading...

DNA GINKGO BIOWORKS HOLDINGS INC Management Changes 8-K Filing

GNKG

DN

GINKGO BIOWORKS HOLDINGS INC

(DNA)

2025 8-K

Stock Purchase Agreement

Financial Results

Management Transition

Q3 Financial Results

Sales Agreement Signed

Settlement Announcement

Financial Statements

Financial Statements

Financial Results

Management Changes

Stock Split Approval

Results of Operations and F...

Restructuring Plan and Head...

Annual Meeting of Shareholders

Delisting Notice

Financial Results and Restr...

Changes in Registrant s Cer...

Earnings Reports

Earnings Reports

Earnings Reports

Bylaws Amendment

Bankruptcy or insolvency

Acquisition and Financial U...

Financial Results Announcement

Annual Meeting of Shareholders

Financial Results Announcement

Resignation and Appointment

Disclosure of Bank Closure

Financial Results Announcement

Acquisition of Zymergen Inc.

Earnings Reports

External Links:

On December 18, 2025, Ginkgo Bioworks announced a management transition where Dr. Reshma Shetty will pass her COO duties to Jennifer Wipf and CEO Dr. Jason Kelly as of January 1, 2026, but will continue as President and Board member focusing on expanding cell engineering services.

AI Assistant

GINKGO BIOWORKS HOLDINGS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.